Healthcare Small Cap Stocks
Healthcare, medical devices, and health IT small caps — companies innovating in diagnostics, treatment delivery, and healthcare administration at compelling valuations.
| Ticker | Company | Price | Mkt Cap | P/E | Rev. Growth | Upside |
|---|---|---|---|---|---|---|
| VIAV | Viavi Solutions | $49.51 +1.08% | $12.13B | — | 42.8% | 30.1% |
| ENSG | Ensign Group | $171.94 +0.15% | $10.05B | 28x | 18.4% | 28.2% |
| STVN | Stevanato Group | $18.03 +1.01% | $4.92B | 30.6x | 6.6% | 37.7% |
| TVTX | Travere Therapeutics | $44.43 -0.69% | $4.13B | — | 55.6% | 20.6% |
| IRTC | iRhythm Technologies | $116.56 -1.11% | $3.83B | — | 25.7% | 55.2% |
| MMSI | Merit Medical Systems | $64.17 +0.85% | $3.83B | 27.7x | 7.5% | 41.2% |
| NVST | Envista Holdings | $23.43 -0.85% | $3.81B | 57.2x | 14.4% | 27.4% |
| ALHC | Alignment Healthcare | $16.35 -0.12% | $3.38B | 163.5x | 33.3% | 53.9% |
| CLDX | Celldex Therapeutics | $30.73 +0.49% | $2.41B | — | -97.8% | 90.1% |
| LMAT | LeMaitre Vascular | $97.75 -1.78% | $2.23B | 35.9x | 11.2% | 21.5% |
| NVCR | NovoCure | $17.96 +0.34% | $2.08B | — | 12.3% | 46.4% |
| OMCL | Omnicell | $44.41 +1.49% | $2.02B | 100.9x | 14.9% | 38% |
| ADMA | ADMA Biologics | $8.24 -2.6% | $1.91B | 12.1x | 15.9% | 103.3% |
| AGIO | Agios Pharmaceuticals | $28.14 -2.26% | $1.67B | — | 137.7% | 46.1% |
| ATEC | Alphatec Holdings | $8.27 +0.49% | $1.27B | — | 13.6% | 109.6% |
| CNMD | Conmed Corporation | $37.26 +0.65% | $1.12B | 21.1x | -1.3% | 6.3% |
| TNDM | Tandem Diabetes Care | $14.96 -5.04% | $1.03B | — | 5.5% | 104% |
| USPH | US Physical Therapy | $62.03 -0.58% | $944M | 124.1x | 7.9% | 51% |
| XNCR | Xencor | $11.31 +0.35% | $838.5M | — | -86.2% | 152% |
| INMD | InMode | $13.74 -0.65% | $835.5M | 10.2x | 5.3% | 12.8% |
| HSTM | HealthStream | $23.81 +0.59% | $695.6M | 35.5x | 10.5% | 34.4% |
| EOLS | Evolent Health | $6.09 -5.58% | $401.1M | — | 6.7% | 140.8% |
| EMBC | Embecta Corp | $3.32 +0% | $197M | 1.8x | -14.4% | 20.5% |
| TMCI | Treace Medical Concepts | $2.78 -2.11% | $180.3M | — | -10.2% | 43.9% |
| AMWL | Amwell | $8.00 +1.14% | $133.7M | — | -17.9% | -6.3% |
| TELA | Tela Bio | $0.89 -3.51% | $39.8M | — | 2.9% | 152.8% |
| CTSO | Cytosorbents Corporation | $0.46 +0.17% | $28.9M | — | 1.6% | 1039.3% |
Analysis and Context
This sector screener currently shows 27 stocks from the selected industry segment — updated daily. The average P/E ratio is 49.9x. The average revenue growth rate is 8.2%. Sectors move through cyclical phases strongly correlated with macro factors — interest rates, GDP growth, commodity prices, and regulatory environment all drive sector dynamics. Analysts see an average of 92.6% upside in these sector names. Compare metrics against the sector average to identify relative over- and undervaluations. Sector concentration increases portfolio risk — maintain adequate diversification across industries and business models.
Ready to invest?
Compare the best brokers for US and European stocks — fees, platforms and account types side by side.
Compare brokers →